Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$235.0 - $310.7 $470,000 - $621,400
-2,000 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$175.6 - $291.43 $75,508 - $125,314
-430 Reduced 17.7%
2,000 $541,000
Q4 2020

Feb 10, 2021

SELL
$174.98 - $272.83 $42,345 - $66,024
-242 Reduced 9.06%
2,430 $425,000
Q3 2020

Nov 12, 2020

SELL
$185.27 - $238.73 $14,080 - $18,143
-76 Reduced 2.77%
2,672 $519,000
Q2 2020

Aug 10, 2020

BUY
$153.32 - $191.72 $19,471 - $24,348
127 Added 4.85%
2,748 $491,000
Q4 2019

Jan 31, 2020

BUY
$134.81 - $177.8 $168,377 - $222,072
1,249 Added 91.03%
2,621 $431,000
Q3 2019

Oct 31, 2019

BUY
$131.82 - $183.4 $180,857 - $251,624
1,372 New
1,372 $185,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.25B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.